Invitae’s business operations are heading to a new home. Under a bankruptcy auction, Labcorp was selected as the winning bidder for the firm’s genetic testing services, digital health solutions, and ...
Invitae Corporation (NYSE: NVTA), a genetic information company, has announced that it has more than doubled the size of its genetic testing platform to include more than 600 genes and will begin ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Invitae cut about 1,000 jobs ...
Law360 (April 25, 2024, 5:58 PM EDT) -- SoftBank-backed genetic testing company Invitae has informed a New Jersey bankruptcy judge that its asset sale auction resulted in a successful $239 million ...
SAN FRANCISCO, Nov. 15, 2017 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), one of the fastest growing genetic information companies, today announced it has completed its acquisition of CombiMatrix ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. San Francisco genetic testing firm Invitae succeeded this ...
Results will be delivered through Labcorp’s new patient portal and its MyLabcorp app. (Labcorp) Labcorp is launching the Marker by Labcorp Genetic Health Panel, a new direct-to-consumer genetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results